Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Intensive Neurowave Emotional Stimulation (INES)

NCT: NCT06204172 · COMPLETED

NCT IDNCT06204172
StatusCOMPLETED
Start Date2023-12-14
Completion2025-03-30

Brief Summary

This is a randomized and controlled pilot study investigating the effects of intensive emotional stimulation with neurological waves (INES) on cognitive-motor functions in patients diagnosed with Vegetative State (VS) and Minimally Conscious State (MCS) following severe brain injury. The study aims to enroll at least 20 patients aged between 18 and 65 over 18 months. Patients will be recruited from the Neurorehabilitation Unit of Piedmont Hospital, IRCCS Centro Neurolesi Bonino Pulejo in Messina. The experimental group will receive multisensory stimulation using Neurowave (INES) for four weeks, five days a week, 45 minutes per session. The control group will undergo a traditional multisensory stimulation program. Enrollment will use simple random sampling to minimize bias. Caregivers will provide biographical information, and both groups will be monitored using event-related potentials. Clinical scales will evaluate cognitive-motor outcomes at different time points. The study includes a one-month follow-up to assess long-term results. Data will be collected and exported for statistical analysis.

Frequently Asked Questions

What is Intensive Neurowave Emotional Stimulation (INES)?

Intensive Neurowave Emotional Stimulation (INES) is a clinical trial registered under NCT06204172. Current status: COMPLETED.

What is the status of NCT06204172?

The current status of NCT06204172 (Intensive Neurowave Emotional Stimulation (INES)) is: COMPLETED.

When did Intensive Neurowave Emotional Stimulation (INES) start?

Intensive Neurowave Emotional Stimulation (INES) started on 2023-12-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.